Development of clinical manifestations in antiphospholipid antibodies carriers according to the 2023 acr/EULAR serological domains
Sign Up to like & getrecommendations! Published in 2025 at "Blood"
DOI: 10.1182/blood-2025-851
Abstract: INTRODUCTION Antiphospholipid syndrome (APS) is a thrombophilic disorder defined by thrombotic/obstetric events and persistent antiphospholipid antibodies (aPL). The 2023 ACR/EULAR classification criteria introduced a novel point-based system, but the prognostic value and ability to stratify… read more here.
Keywords: risk; 2023 acr; acl anti; acr eular ... See more keywords